In response to increased public interest, the Food and Drug Administration (FDA) provides data on the demographic makeup of clinical trials for recently approved drugs. In 2018, for example, FDA approved 59 new drugs based on the results of clinical trials involving nearly 44,000 participants. Of those, 69% were white and 56% were women. In […]
January is Cervical Health Awareness Month, an ideal time to call attention to one of the most preventable cancers.
The good news is that cervical cancer rates have declined significantly because of widespread use of the Pap screening test. Even better, cervical cancer can now be prevented by a vaccine that targets HPV, the virus that […]
This time of year, it’s customary to assess what you’ve accomplished and what you hope to achieve over the next 12 months. At Clinical Research Pathways, we can point to significant progress in 2019 as well as plans to build on these efforts in 2020 and beyond.
Those of you who are familiar with our work […]
[News Release] Clinical Research Pathways Partners with WellStar Health System to Increase Diversity in Clinical Trials
Grant to promote minority participation in cancer research
ATLANTA, December 12, 2019—Clinical Research Pathways is partnering with WellStar Health System to increase diversity in oncology research to help ensure that new cancer medicines are effective for patients of all races and ethnicities.
The two organizations—a nonprofit focused on creating pathways to new medicines and treatments, and one […]
This #GivingTuesday, help us advance health equity
Everyone should benefit from clinical trials. But because some racial and ethnic groups are underrepresented in clinical research, they might benefit less.
Most of today’s medicines and other therapies are based on data obtained primarily from white clinical trial […]
A blog post by Clinical Research Pathways Executive Director Marjorie A. Speers, Ph.D.
The two young girls seem remarkably similar. They live in the same neighborhood and are in the same class in the same school. They see the same pediatrician and take the same medication to treat their asthma. And that’s where their stories […]
Almost every medicine you take has been tested beforehand in a clinical trial. But if you’re not white or male, there’s a good chance people like you were not included in the trial group—so the trial results might not apply. Maybe a different dose or a different medicine would be more effective.
We can’t be confident […]
Lung cancer is the most common cancer worldwide and the leading cause of cancer deaths among U.S. men and women. The news is even worse for black Americans, who are more likely than any other racial or ethnic group to get—and die from—lung cancer.
November is Lung Cancer Awareness Month, a time to call attention to […]
A blog post by Derek West, M.D., Clinical Research Pathways Board of Directors
Talk with almost any physician about his or her path to success, and chances are it includes a mentor. When the work gets difficult and the doubts set in, the support, encouragement, and guidance of a mentor can make all the difference.
That’s especially […]
[Forbes Article] Diversity Is Severely Lacking Among Clinical Trial Participants — How Can We Solve This Problem?
Article published in “Forbes”
Written by Morris Panner, CEO of Ambra Health, with reference to Clinical Research Pathways
Rigorous clinical trials are key to ensuring that newly developed drugs and treatments are both safe and effective for patients. Success in trials gives researchers, regulatory bodies, and patients reason to believe that a drug or […]